Twice a year, the Alliance for Regenerative Medicine (ARM) surveys the cell and gene therapy landscape to advance the field and provide an update to their members, stakeholders, and the public. In this podcast, Stephen Majors, Senior Director of Public Affairs, reviews key insights from ARM's updated cell and gene therapy sector report for the first half of 2022. ARM is the leading international advocacy organization dedicated to realizing the promise of regenerative medicines and advanced therapies.